ARCHIVES

In Brief: Holland Retires As Center Director, Replaced By NCI’s Aaronson; Lab Chiefs Leaving NCI

This article is from The Cancer Letter archive.

Vol. 19 No. 37 | September 24, 1993

Download PDF Visit The Full Archive

Related Articles

ODAC Oks Melphalan Injection WR-2721 Needs More Data

February 7, 1992

Also in this 8-page issue: Despite press reports, no settlement date yet for Bristol-Myers pact with federal prosecutors.

June 10, 2005

Genentech Move Nixes Hospital Discounts: Avastin, Herceptin, Rituxan Now Sold Under Tighter Control by Drug Maker

October 3, 2014

NCI Publishes FOA For Trials Network Program

July 27, 2012

Organ Systems Extension to CNS, Aerodigestive Tract Considered

July 26, 1985

New Treatment For CML Could Be Model for Molecular Target-Based Therapeutics

December 10, 1999